Evidence map›Paper›PMID 31731216›Full record

ReviewCurrent opinion in genetics & development2019

The origin and evolution of cell-intrinsic antibacterial defenses in eukaryotes.

Daniel J Richter, Tera C Levin

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. From Species to Regional and Local Specialization of Intestinal Macrophages.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Daniel J RichterInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Barcelona, Catalonia, Spain. Electronic address: daniel.j.richter@gmail.com.
Tera C LevinDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. Electronic address: tlevin@fredhutch.org.
Fred Hutch Cancer Center · USPompeu Fabra University · ES

Funding

Using Legionella-amoeba co-evolution to reveal new modes of immunity and pathogenesisK99AI139344 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LEVIN, TERA CATHERINE · 2018 to 2019
$217k
NIAID NIH HHS K99 AI139344
6 · The paper itself

Abstract

To survive in a world dominated by bacteria, eukaryotes have evolved numerous self-defense strategies. While some defenses are recent evolutionary innovations, others are ancient, with roots early in eukaryotic history. With a focus on antibacterial immunity, we highlight the evolution of pattern recognition receptors that detect bacteria, where diverse functional classes have been formed from the repeated use and reuse of a small set of protein domains. Next, we discuss core microbicidal strategies shared across eukaryotes, and how these systems may have been co-opted from ancient cellular mechanisms. We propose that studying antibacterial responses across diverse eukaryotes can reveal novel modes of defense, while highlighting the critical innovations that occurred early in the evolution of our own immune systems.

Indexed as

Bacterial Physiological PhenomenaEvolution, MolecularAutophagyBacteriaEukaryotaEukaryotic CellsHost Microbial InteractionsNLR ProteinsPhagocytosisPhylogenyProtein DomainsReactive Oxygen SpeciesReceptors, Pattern RecognitionToll-Like ReceptorsNLR ProteinsReactive Oxygen SpeciesReceptors, Pattern RecognitionToll-Like Receptors

Identifiers

PMID31731216
PMCPMC9275444
OpenAlexW2983310029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.